Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2017
Headcount
2
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
NevaBio is engaged in the discovery and development of an anticancer immunotherapy treatment.
Q&A
- What is NevaBio's primary focus?
- NevaBio is engaged in the discovery and development of an anticancer immunotherapy treatment, with a one-liner describing their focus as "Immunotherapy for Cancer Prevention."
- When was NevaBio founded?
- NevaBio was founded in September 2017.
- What is the current status of NevaBio?
- NevaBio is currently inactive, having ceased to operate in April 2021.
- Where is NevaBio headquartered?
- NevaBio is headquartered in Tel Aviv-Yafo, Israel.
- How many employees did NevaBio have?
- NevaBio had 2 employees, falling into the 1-10 employees bucket.
- What is NevaBio's primary sector?
- NevaBio's primary sector is Health Tech & Life Sciences.
- What business models did NevaBio utilize?
- NevaBio utilized a B2B business model.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
therapeuticsoncologypharmaceuticalscancer-therapyimmunotherapypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2017-9 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Non Active, Apr 2021 ceased to operate |